Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting
- 1 January 2012
- journal article
- Published by International Union Against Tuberculosis and Lung Disease in The International Journal of Tuberculosis and Lung Disease
- Vol. 16 (1) , 90-97
Abstract
SETTING: Recent studies suggest that the prevalence of drug-resistant tuberculosis (TB) in sub-Saharan Africa may be rising. This is of concern, as human immunodeficiency virus (HIV) co-infection in multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB has been associated with exceedingly high mortality rates. OBJECTIVE: To identify risk factors associated with mortality in MDR- and XDR-TB patients co-infected with HIV in South Africa. DESIGN: Case-control study of patients who died of all causes within 2 years of diagnosis with MDR- or XDR-TB. RESULTS: Among 123 MDR-TB patients, 78 (63%) died following diagnosis. CD4 count ≤ 50 (HR 4.64, P = 0.01) and 51–200 cells/mm3 (HR 4.17, P = 0.008) were the strongest independent risk factors for mortality. Among 139 XDR-TB patients, 111 (80%) died. CD4 count ≤50 cells/mm3 (HR 4.46, P = 0.01) and resistance to all six drugs tested (HR 2.54, P = 0.04) were the principal risk factors. Use of antiretroviral therapy (ART) was protective (HR 0.34, P = 0.009). CONCLUSIONS: Mortality due to MDR- and XDR-TB was associated with greater degree of immunosuppression and drug resistance. Efforts to reduce mortality must focus on preventing the amplification of resistance by strengthening TB treatment programs, as well as reducing the pool of immunosuppressed HIV-infected patients through aggressive HIV testing and ART initiation.Keywords
This publication has 20 references indexed in Scilit:
- Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.2009
- Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysisThe Lancet Infectious Diseases, 2009
- Epidemiology and clinical management of XDR-TB: a systematic review by TBNETEuropean Respiratory Journal, 2009
- Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South AfricaAIDS, 2009
- Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2008
- Underreported Threat of Multidrug-Resistant Tuberculosis in AfricaEmerging Infectious Diseases, 2008
- Multidrug-resistant tuberculosisBMC Infectious Diseases, 2008
- Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment FailuresPLOS ONE, 2007
- HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect StormThe Journal of Infectious Diseases, 2007
- Time to Sputum Culture Conversion in Multidrug-Resistant Tuberculosis: Predictors and Relationship to Treatment OutcomeAnnals of Internal Medicine, 2006